Tuesday, April 7, 2020

KPTI To Test XPOVIO In COVID-19, PTCT Will Have To Wait, SAGE Slashes Workforce

Today's Daily Dose brings you news about Idera's private placement; Karyopharm's COVID-19 drug initiative; Merck's regulatory catalyst in June; delay in FDA decision of PTC Therapeutics' spinal muscular atrophy drug candidate and Sage Therapeutics' cost-cutting measures.

from RTT - Biotech https://ift.tt/2wo09HL
via IFTTT

No comments:

Post a Comment